Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer science

Showing results (891-900 of 7,117) with videos related to

Pageof 712
Sort By:
Cancer Science|December 19, 2019
Abemaciclib, a CDK4/6 inhibitor, exerts preclinical activity against aggressive germinal center-derived B-cell lymphomasYuka Tanaka, Shuji Momose, Takayuki Tabayashi, et al.
Cancer Science|December 20, 2019
Ubiquitination of NOTCH2 by DTX3 suppresses the proliferation and migration of human esophageal carcinomaXin-Yu Ding, Hai-Yang Hu, Ke-Nan Huang, et al.
Cancer Science|December 20, 2019
YES1 activation induces acquired resistance to neratinib in HER2-amplified breast and lung cancersTatsuaki Takeda, Hiromasa Yamamoto, Ken Suzawa, et al.
Cancer Science|February 27, 2020
Is the catch-up program of HPV vaccination for Japanese adult women effective or not?Tetsuji Kurokawa
Cancer Science|February 28, 2020
SPH3643: A novel cyclin-dependent kinase 4/6 inhibitor with good anticancer efficacy and strong blood-brain barrier permeabilityXueMei Liao, Yuan Hong, Yu Mao, et al.
Cancer Science|March 6, 2020
Artificial intelligence in oncologyHideyuki Shimizu, Keiichi I Nakayama
Cancer Science|March 19, 2020
Tumor microenvironment characterization identifies two lung adenocarcinoma subtypes with specific immune and metabolic stateJianbing Huang, Jiagen Li, Sufei Zheng, et al.
Cancer Science|March 22, 2020
Helicobacter pylori CagA oncoprotein interacts with SHIP2 to increase its delivery into gastric epithelial cellsYumiko Fujii, Naoko Murata-Kamiya, Masanori Hatakeyama
Cancer Science|March 12, 2020
Long-term efficacy and predictive correlates of response to nivolumab in Japanese patients with esophageal cancerKen Kato, Yuichiro Doki, Takashi Ura, et al.
Cancer Science|March 13, 2020
Curcumin β-D-glucuronide exhibits anti-tumor effects on oxaliplatin-resistant colon cancer with less toxicity in vivoHitomi Ozawa-Umeta, Atsuhiro Kishimoto, Atsushi Imaizumi, et al.
Pageof 712

Showing results (891-900 of 7,117) with videos related to

Sort By:
Pageof 712
Cancer Science|December 19, 2019
Abemaciclib, a CDK4/6 inhibitor, exerts preclinical activity against aggressive germinal center-derived B-cell lymphomasYuka Tanaka, Shuji Momose, Takayuki Tabayashi, et al.
Cancer Science|December 20, 2019
Ubiquitination of NOTCH2 by DTX3 suppresses the proliferation and migration of human esophageal carcinomaXin-Yu Ding, Hai-Yang Hu, Ke-Nan Huang, et al.
Cancer Science|December 20, 2019
YES1 activation induces acquired resistance to neratinib in HER2-amplified breast and lung cancersTatsuaki Takeda, Hiromasa Yamamoto, Ken Suzawa, et al.
Cancer Science|February 27, 2020
Is the catch-up program of HPV vaccination for Japanese adult women effective or not?Tetsuji Kurokawa
Cancer Science|February 28, 2020
SPH3643: A novel cyclin-dependent kinase 4/6 inhibitor with good anticancer efficacy and strong blood-brain barrier permeabilityXueMei Liao, Yuan Hong, Yu Mao, et al.
Cancer Science|March 6, 2020
Artificial intelligence in oncologyHideyuki Shimizu, Keiichi I Nakayama
Cancer Science|March 19, 2020
Tumor microenvironment characterization identifies two lung adenocarcinoma subtypes with specific immune and metabolic stateJianbing Huang, Jiagen Li, Sufei Zheng, et al.
Cancer Science|March 22, 2020
Helicobacter pylori CagA oncoprotein interacts with SHIP2 to increase its delivery into gastric epithelial cellsYumiko Fujii, Naoko Murata-Kamiya, Masanori Hatakeyama
Cancer Science|March 12, 2020
Long-term efficacy and predictive correlates of response to nivolumab in Japanese patients with esophageal cancerKen Kato, Yuichiro Doki, Takashi Ura, et al.
Cancer Science|March 13, 2020
Curcumin β-D-glucuronide exhibits anti-tumor effects on oxaliplatin-resistant colon cancer with less toxicity in vivoHitomi Ozawa-Umeta, Atsuhiro Kishimoto, Atsushi Imaizumi, et al.
Pageof 712